PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Alfuzosin hydrochloride - Lower urinary tract symptoms - MEN
PAD Profile : Alfuzosin hydrochloride - Lower urinary tract symptoms - MEN
Keywords :
BPH, LUTS, urinary tract symptoms, urinary retention
Brand Names Include :
Xatral
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
06 December 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN recommends Alfuzosin MR (modified release) as a treatment option for men with recurrent acute retention or acute on chronic urinary retention.
Alfuzosin MR (modified release) will be considered GREEN on the traffic light system for this licensed indication
Associated BNF Codes
07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.01. Drugs for urinary retention